For years, one of the biggest concerns among Medicare beneficiaries was the potentially unlimited out-of-pocket spending on prescription drugs. Once you passed through the coverage gap, you still owed a percentage of costs in the catastrophic phase — and for people taking expensive medications, those bills could be devastating. Starting in 2025, that changed. Thanks to the Inflation Reduction Act (IRA), Medicare Part D now includes an annual hard cap on out-of-pocket prescription drug costs — set at $2,100 for 2026 (adjusted annually for inflation from the original $2,000 in 2025). Here is everything you need to know about how this cap works and what it means for your finances.
How the $2,000 Cap Came About
The Inflation Reduction Act, signed into law in August 2022, included several major reforms to Medicare prescription drug pricing. Among the most impactful was the creation of an annual out-of-pocket maximum for Part D beneficiaries.
Before this law, Part D had a coverage structure that included a deductible, an initial coverage phase, a coverage gap (formerly the "donut hole"), and a catastrophic coverage phase. Even in the catastrophic phase, beneficiaries were responsible for 5% of drug costs — a percentage that could translate to hundreds or even thousands of dollars per month for high-cost specialty medications.
The IRA eliminated that 5% catastrophic coinsurance and established a firm annual ceiling on what you pay out of pocket for covered Part D drugs. This cap took effect on January 1, 2025, at $2,000, and has been adjusted to $2,100 for 2026.
How the Cap Works in Practice
The $2,100 out-of-pocket cap (for 2026) applies to your share of costs for covered prescription drugs under your Part D plan. Here is what counts toward the cap and what does not:
Counts toward the $2,100 limit:
- Your annual Part D deductible payments
- Copayments and coinsurance you pay for covered drugs during the initial coverage phase
- Costs you would have paid in the coverage gap
Does not count toward the limit:
- Your monthly Part D premium
- Costs for drugs that are not on your plan's formulary
- Payments made for drugs purchased at out-of-network pharmacies (unless it is an emergency)
Once your qualifying out-of-pocket spending reaches $2,100 in a calendar year, you pay nothing more for covered Part D drugs for the rest of that year. Your plan and the federal government absorb the remaining costs.
The Medicare Prescription Payment Plan
Reaching the $2,100 cap is still a significant expense, and for many people on fixed incomes, paying large amounts early in the year can be a hardship. To address this, the IRA also created the Medicare Prescription Payment Plan, which allows you to spread your out-of-pocket drug costs across the entire year in predictable monthly installments.
Key features of the payment plan:
- Opt-in program: You must choose to participate. It is not automatic.
- Available through your Part D plan: Contact your plan directly to enroll.
- No interest or fees: The monthly payments are calculated by dividing your estimated annual out-of-pocket costs into equal installments. There is no finance charge.
- Adjusts as needed: If your actual costs differ from the initial estimate — for example, if you start a new expensive medication mid-year — your monthly amount may be recalculated.
- Monthly billing: You will receive a bill from your Part D plan each month alongside your regular premium statement.
This payment plan is particularly valuable for beneficiaries who fill expensive prescriptions early in the year and would otherwise face a large bill in January or February before hitting the cap.
Who Benefits Most from the Cap
The out-of-pocket cap benefits all Part D enrollees, but the savings are most dramatic for people who take high-cost medications. Before the cap, a beneficiary taking a specialty drug that costs $10,000 per month could easily spend $5,000 or more per year out of pocket. Under the new rules, that same person pays no more than $2,100.
The groups that see the greatest financial relief include:
- Cancer patients taking oral chemotherapy or targeted therapy drugs
- People with autoimmune conditions such as rheumatoid arthritis, psoriasis, or multiple sclerosis who rely on biologic medications
- Transplant recipients on long-term immunosuppressive therapy
- Hepatitis C patients taking high-cost antiviral regimens
- Anyone taking multiple brand-name medications whose combined costs previously pushed them deep into the coverage gap
If you take only generic medications and your total annual drug costs are modest, you may never approach the $2,100 threshold. But even in that case, the cap provides a financial safety net — you know your worst-case scenario for drug spending in any given year.
Impact on Part D Plan Comparison
The out-of-pocket cap changes how you should evaluate and compare Part D plans during Open Enrollment (October 15 through December 7 each year). Previously, choosing a plan with a lower deductible or more generous coverage gap benefits could save you thousands of dollars. With the annual cap in place, the dynamics shift:
- Premiums matter more: Since your maximum out-of-pocket spending is now capped, the difference between plans often comes down to monthly premiums. A plan with a slightly higher premium but lower copays may not save you money if you would hit the cap regardless.
- Formulary coverage is still critical: The cap only applies to covered drugs. If your medications are not on a plan's formulary, you pay full price and those costs do not count toward the cap. Always verify that your specific drugs are covered.
- Pharmacy networks still matter: Costs at out-of-network pharmacies may not count toward your cap. Make sure your preferred pharmacy is in-network.
- Deductible considerations: Some plans have no deductible, while others charge up to the maximum (currently $615 in 2026). That deductible counts toward the cap, so a plan with a higher deductible is not necessarily worse — it just shifts when you hit the $2,100 limit.
The Cap and the Bigger Picture
The out-of-pocket cap is one piece of a broader set of Part D reforms under the Inflation Reduction Act. It works alongside Medicare drug price negotiation, which is lowering the cost of selected high-cost medications, and the inflation rebate provision, which penalizes manufacturers who raise prices faster than inflation.
Together, these policies are reshaping the financial landscape of prescription drug coverage for Medicare beneficiaries. The cap alone is estimated to save approximately 1.5 million beneficiaries more than $1,000 per year compared to what they would have paid under the old structure.
What You Should Do
If you are a current Medicare Part D enrollee, here are steps to take:
- Review your current plan to understand how the cap affects your expected costs for the year
- Ask about the Medicare Prescription Payment Plan if you want to spread your costs into monthly installments rather than paying large sums upfront
- During Open Enrollment, compare plans using the Medicare Plan Finder tool, paying close attention to premiums, formulary coverage, and pharmacy networks
- Talk to your pharmacist or plan representative about switching to lower-cost alternatives where possible — the less you spend, the more of the $2,100 cap you preserve for unexpected needs
The annual cap is a meaningful financial protection that gives you certainty about the maximum you will spend on prescriptions each year. Take full advantage of it by choosing your plan carefully and exploring the payment plan option if monthly budgeting suits your financial situation.